ジェイゾロフト錠２５ｍｇ

基本情報

項目	値
DrugBank ID	DB01104
エビデンスレベル	L5（計算予測のみ）
予測適応症数	40
日本商品名（例）	ジェイゾロフト錠１００ｍｇ, ジェイゾロフト錠１００ｍｇ（選）, ジェイゾロフト錠２５ｍｇ

うつ病・うつ状態、パニック障害

以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。

#	適応症	スコア	ソース
1	obsessive-compulsive disorder	99%	DL
2	dysthymic disorder	99%	DL
3	anxiety disorder	99%	DL
4	histrionic personality disorder (disease)	99%	DL
5	schizotypal personality disorder	99%	DL
6	paranoid personality disorder	99%	DL
7	schizoid personality disorder	99%	DL
8	benign paroxysmal torticollis of infancy	99%	DL
9	agoraphobia	99%	DL
10	dependent personality disorder	99%	DL
11	narcissistic personality disorder	99%	DL
12	endogenous depression	98%	DL
13	major depressive disorder	98%	DL
14	phobic disorder	97%	DL
15	manic bipolar affective disorder	97%	DL
16	avoidant personality disorder	97%	DL
17	Ohdo syndrome and variants	97%	DL
18	myofascial pain syndrome	97%	DL
19	blepharophimosis - intellectual disability syndrome, Ohdo type	97%	DL
20	melancholia	97%	DL
21	neurotic depression	97%	DL
22	attention deficit-hyperactivity disorder	97%	DL
23	trigeminal nerve neoplasm	96%	DL
24	chondromyxoid fibroma	96%	DL
25	major affective disorder	95%	DL
26	attention deficit hyperactivity disorder, inattentive type	95%	DL
27	Keppen-Lubinsky syndrome	95%	DL
28	faciodigitogenital syndrome	95%	DL
29	unipolar depression	94%	DL
30	specific developmental disorder	94%	DL
31	vitamin B12-responsive methylmalonic acidemia	94%	DL
32	post-traumatic stress disorder	93%	DL
33	ligneous conjunctivitis	93%	DL
34	neurotic disorder	92%	DL
35	childhood apraxia of speech	92%	DL
36	congenital isolated adrenocorticotropic hormone deficiency (disease)	92%	DL
37	bipolar disorder	92%	DL
38	autosomal dominant slowed nerve conduction velocity	91%	DL
39	surfactant metabolism dysfunction, pulmonary	91%	DL
40	social phobia	0%	DL

これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。臨床応用には必ず適切な検証が必要です。